Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. Valbenazine Ditosylate
2. 1639208-54-0
3. Valbenazine Tosilate
4. Valbenazine (tosylate)
5. Nbi-98854 Ditosylate
6. Valbenazine Tosylate [usan]
7. 5sml1t733b
8. 1639208-54-0 (tosylayte)
9. Valbenazine Tosilate (jan)
10. Valbenazine Tosylate (usan)
11. Valbenazine Tosilate [jan]
12. (2r,3r,11br)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-yl L-valinate Di(4-methylbenzenesulfonate)
13. L-valine, (2r,3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-yl Ester, 4-methylbenzenesulfonate (1:2)
14. Ingrezza (tn)
15. Nbi-98854 Tosylate
16. Unii-5sml1t733b
17. Valbenazine Tosylate (1:2)
18. Chembl3707248
19. Schembl18863051
20. Valbenazine Tosylate [mi]
21. Dtxsid201026308
22. Hy-16771a
23. S9500
24. Valbenazine Tosilate [who-dd]
25. Ccg-270445
26. Valbenazine Tosylate [orange Book]
27. Cs-0030913
28. D10999
29. Q27262815
30. (2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-yl L-valinate Bis(4-methylbenzenesulfonate)
31. [(2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizin-2-yl] (2s)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic Acid
Molecular Weight | 763.0 g/mol |
---|---|
Molecular Formula | C38H54N2O10S2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 10 |
Exact Mass | 762.32198827 g/mol |
Monoisotopic Mass | 762.32198827 g/mol |
Topological Polar Surface Area | 200 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 776 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2037-10-10
US Patent Number : 10993941
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2036-10-28
US Patent Number : 10844058
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-10-28
Patent Expiration Date : 2037-10-10
US Patent Number : 10993941
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2037-10-10
US Patent Number : 10952997
Drug Substance Claim :
Drug Product Claim :
Application Number : 209241
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-10-10
Patent Expiration Date : 2036-10-28
US Patent Number : 10851104
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-10-28
Patent Expiration Date : 2036-12-22
US Patent Number : 10919892
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-12-22
Patent Expiration Date : 2027-11-08
US Patent Number : 8357697
Drug Substance Claim :
Drug Product Claim :
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-11-08
Patent Expiration Date : 2036-10-28
US Patent Number : 10065952
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-3055
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-10-28
Patent Expiration Date : 2031-04-11
US Patent Number : 8039627
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209241
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-04-11
Patent Expiration Date : 2036-10-28
US Patent Number : 10844058
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218390
Patent Use Code : U-1995
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-10-28
Exclusivity Code : ODE-440
Exclusivity Expiration Date : 2030-08-18
Application Number : 209241
Product Number : 2
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 209241
Product Number : 2
Exclusivity Details :
Exclusivity Code : ODE-440
Exclusivity Expiration Date : 2030-08-18
Application Number : 209241
Product Number : 1
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 209241
Product Number : 1
Exclusivity Details :
Exclusivity Code : ODE-440
Exclusivity Expiration Date : 2030-08-18
Application Number : 209241
Product Number : 3
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 209241
Product Number : 3
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 218390
Product Number : 2
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 218390
Product Number : 3
Exclusivity Details :
Exclusivity Code : I-925
Exclusivity Expiration Date : 2026-08-18
Application Number : 218390
Product Number : 1
Exclusivity Details :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?